The current study showed the effectiveness of tafenoquine relative to 7-day primaquine and the overall effectiveness of the treatment algorithm, supporting the widespread adoption of quantitative G6PD testing and tafenoquine for P vivax radical cure across malaria-endemic regions in Brazil and potentially across South America. Here, G6PD is linked to malaria.